A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
NCT07655934 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-06-24
Summary
The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.
Conditions
Interventions
- OTHER
-
Survey completion
Surveys will evaluate dietary quality, physical activity, tobacco use, demographic and socio-economic/occupation factors and perspectives about participation in biomedical/biospecimen research.
- OTHER
-
Urine specimen banking
The study team will collect the first urine of the day from these volunteers on the same day that they complete the lifestyle questionnaires. The urine will be used for metabolomics testing via Nuclear Magnetic Resonance (NMR) spectroscopy and will be correlated with the survey data.
- OTHER
-
Qualitative interviews
After the survey and urine specimen have been received, participants will be scheduled for online or in-person semi-structured interviews. Semi-structured interviews will be conducted at baseline (either before or after surgery, but not both for the same individual) and at follow up.
Sponsors & Collaborators
-
Penn State University
collaborator OTHER -
Abramson Cancer Center at Penn Medicine
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-20
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
NCT05721326 ·Status: COMPLETED ·Phase: NA
-
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
NCT06780176 ·Status: RECRUITING
-
Endocrine Disruptors and Life STILe in Breast Cancer Development
NCT05748353 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
NCT01992471 ·Status: COMPLETED
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT07076147 ·Status: RECRUITING
-
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake
NCT02517593 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703 ·Status: RECRUITING
-
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT00823654 ·Status: RECRUITING
-
Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives
NCT01612338 ·Status: COMPLETED ·Phase: NA
-
Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors
NCT01627366 ·Status: COMPLETED ·Phase: NA
-
Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening
NCT05731453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
Study of Blood Samples in Patients With Breast Cancer
NCT00959556 ·Status: COMPLETED
-
Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers
NCT07411651 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors
NCT04999826 ·Status: COMPLETED
-
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
NCT01282931 ·Status: COMPLETED
-
Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication
NCT06865755 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST
NCT06979921 ·Status: ACTIVE_NOT_RECRUITING
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NCT00967239 ·Status: UNKNOWN
-
Engaging Diverse Underserved Communities to Bridge the Mammography Divide
NCT01267110 ·Status: COMPLETED ·Phase: NA
-
Cardiometabolic Screening Program
NCT05386719 ·Status: RECRUITING ·Phase: NA
-
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
NCT02278965 ·Status: COMPLETED ·Phase: PHASE1